Medinet Co (TSE:2370) Total Receivables : 円204.5 Mil (As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Medinet Co Total Receivables?

Medinet Co's Total Receivables for the quarter that ended in Mar. 2024 was 円204.5 Mil.

Medinet Co Total Receivables Historical Data

The historical data trend for Medinet Co's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medinet Co Total Receivables Chart

Medinet Co Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Total Receivables

Get a 7-Day Free Trial

345.39

227.33

219.34

171.00

217.62

Medinet Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Receivables	Get a 7-Day Free Trial															172.41	181.24	217.62	225.21	204.45

Medinet Co Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Medinet Co Total Receivables Related Terms

Thank you for viewing the detailed overview of Medinet Co's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Medinet Co (TSE:2370) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medinet Co Ltd (TSE:2370) » Definitions » Total Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-3-12 Shin-Yokohama, Shin-Yokohama Square Building, 14 Floor, Kohoku-ku, Yokohama, JPN, 222-0033

Website

http://www.medinet-inc.co.jp

Medinet Co Ltd is a Japan-based Contract Development and Manufacturing Organization (CDMO). The company is engaged in the research and development of regenerative medical products, investigational products, and specified cell products. MEDINET is a one-stop regenerative medicine and cell therapy solution provider. It provides value chain solutions including personnel training, facility and equipment design, facility operations and management, preparation of standard operating procedures, logistics network, information system, purchasing and production management, quality management solutions to medical institutions, research institutions, and biopharmaceutical companies.

Medinet Co (TSE:2370) Headlines

No Headlines